PRURITUS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA)

被引：0
|
作者：
Younossi, Zobair M. [1 ,2 ,3 ]
Stepanova, Maria [4 ]
Nader, Fatema [4 ]
Bonacci, Martin [5 ]
Wong, Bruce [5 ]
Loomba, Rohit [6 ]
Rinella, Mary E. [7 ]
Noureddin, Mazen [8 ]
Harrison, Stephen A. [9 ]
机构：
[1] Inova Hlth Syst, Inova Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[3] Inova Fairfax Med Campus, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[4] Ctr Outcomes Res Liver Dis, Washington, DC USA
[5] Intercept Pharmaceut Inc, New York, NY USA
[6] Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA
[7] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[8] Cedars Sinai Med Ctr, Fatty Liver Program, Los Angeles, CA 90048 USA
[9] Pinnacle Clin Res, San Antonio, TX USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1690
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [1] THE IMPACT OF PRURITUS ON PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA)
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Harrison, Stephen A.
    Sanyal, Arun J.
    George, Jacob
    Beckebaum, Susanne
    Orr, David W.
    Mazzella, Giuseppe
    Vargas, Victor
    Gluud, Lise L.
    Safadi, Rifaat
    Trotter, James F.
    Behari, Jaideep
    Sheridan, David A.
    Sheikh, Muhammad Y.
    Cawkwell, Gail
    Wong, Bruce
    Bedossa, Pierre
    Goodman, Zachary D.
    Rinella, Mary E.
    HEPATOLOGY, 2019, 70 : 39A - 40A
  • [2] The Impact Of Obeticholic Acid (OCA) On Atherogenic Lipoproteins In Nonalcoholic Steatohepatitis
    Sanyal, Arun J.
    Van Natta, Mark L.
    Yamada, Goro
    Connelly, Margery A.
    Siddiqui, Mohammad
    Wattacheril, Julia
    Neuschwander-Tetri, Brent A.
    Chalasani, Naga P.
    Kowdley, Kris V.
    Diehl, Anna Mae
    Contos, Melissa J.
    Behling, Cynthia A.
    HEPATOLOGY, 2017, 66 : 1136A - 1137A
  • [3] SEPARATE AND COMBINED EFFECTS OF OBETICHOLIC ACID AND WEIGHT LOSS IN NONALCOHOLIC STEATOHEPATITIS (NASH)
    Hameed, B.
    Terrault, N.
    Gill, R.
    Loomba, R.
    Chalasani, N.
    Hoofnagle, J. H.
    Van Natta, M. L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S271 - S271
  • [4] Obeticholic acid for the treatment of nonalcoholic steatohepatitis
    Shah, Raj A.
    Kowdley, Kris, V
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 311 - 321
  • [5] Clinical and Metabolic Effects Associated With Weight Loss and Obeticholic Acid In Nonalcoholic Steatohepatitis (NASH)
    Hameed, Bilal
    Terrault, Norah
    Gill, Ryan M.
    Loomba, Rohit
    Chalasani, Naga P.
    Hoofnagle, Jay H.
    Van Natta, Mark L.
    HEPATOLOGY, 2015, 62 : 331A - 331A
  • [6] Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns
    Polyzos, Stergios A.
    Kountouras, Jannis
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [7] SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF OBETICHOLIC ACID IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS OR CIRRHOSIS
    Alkhouri, Naim
    Poordad, Fred
    Lawitz, Eric J.
    Boyd, Jason
    Edwards, Jeffrey
    HEPATOLOGY, 2019, 70 : 1349A - 1349A
  • [8] ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA): RESULTS FROM REGENERATE PHASE 3 CLINICAL TRIAL
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Harrison, Stephen A.
    Sanyal, Arun J.
    Trotter, James F.
    Sheikh, Muhammad Y.
    Montano-Loza, Aldo J.
    Olveria, Antonio
    Stinton, Laura M.
    Sheridan, David A.
    Vargas, Victor
    Gluud, Lise L.
    Safadi, Rifaat
    Schattenberg, Joern
    Khalili, Mandana
    Orr, David W.
    Peck-Radosavljevic, Markus
    Allison, Michael E.
    Cawkwell, Gail
    Wong, Bruce
    Bedossa, Pierre
    Goodman, Zachary D.
    Rinella, Mary E.
    HEPATOLOGY, 2019, 70 : 1366A - 1368A
  • [9] Improvement in liver histology with obeticholic acid in patients with nonalcoholic steatohepatitis and type 2 diabetes
    Liberman, A.
    McCullough, A.
    Neuschwander-Tetri, B.
    Sanyal, A.
    Abdelmalek, M.
    Gogineni, R.
    Ferguson, B.
    Shringarpure, R.
    Shapiro, D.
    DIABETOLOGIA, 2017, 60 : S574 - S574
  • [10] NASH - Nonalcoholic steatohepatitis
    Blechacz, B
    Stremmel, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (01): : 77 - 90
12345